Company · CIK 0001080014 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Innoviva, Inc. · INVA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 FForm 4 → | Aug 24, 4:15 pm EDT | Marianne ZhenChief Accounting Officer | 1,127 | $21.00 | $23,667 | 56,389 | — | |
| Aug 20, 2026 FForm 4 → | Aug 24, 4:15 pm EDT | Stephen BassoChief Financial Officer | 558 | $21.00 | $11,718 | 88,013 | — | |
| Aug 20, 2026 FForm 4 → | Aug 24, 4:15 pm EDT | Pavel RaifeldChief Executive Officer, Director | 1,130 | $21.00 | $23,730 | 284,799 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.